Last reviewed · How we verify
Compound Vitamin B12
At a glance
| Generic name | Compound Vitamin B12 |
|---|---|
| Also known as | 贯新克 |
| Sponsor | Wei LUO |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome (PHASE3)
- Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults (NA)
- Prototype of Innovative Food Product to Improve Respiratory and Peripheral Muscle Function in Humans
- Evaluation of the Effect of Citicoline and Docosahexaenoic Acid (DHA) on the Visual Function of Patients With Glaucoma (NA)
- Transdermal Iontophoresis of Vitamin B12 Under Three Different Skin Preparations (NA)
- Effect of an Antioxidants Mix on Cognitive Performance and Well Being: The Bacopa, Licopene, Astaxantina, Vitamin B12 (NA)
- Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome. (NA)
- Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults With Hyperhomocysteinemia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Compound Vitamin B12 CI brief — competitive landscape report
- Compound Vitamin B12 updates RSS · CI watch RSS
- Wei LUO portfolio CI